Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia May 21, 2025 7:00 AM EDT | Source: cbdMD Charlotte, North Carolina--(Newsfile Corp. - May 21, 2025) - Herbal Oasis ("Oasis"), the hemp-derived THC- infused social seltzer redefining how people connect, unwind, and celebrate life, is proud to announce a new distribution partnership with Beverage South, a leading distributor serving much of the state of Georgia. Starting this month, Oasis will be available on shelves across Georgia as t ...

cbdMD (YCBD) Q2 2025 Earnings Call May 15, 2025 04:20 PM ET Company Participants Brad Whitford - CAORonan Kennedy - CEO, CFO & Board MemberThomas McGovern - Equity Research AssociateAdam Waldo - Chairman & Managing Member Operator Good afternoon, and welcome to the CBDMD, Inc. Conference Call to discuss results for their second quarter fiscal twenty twenty five period ending 03/31/2025. This afternoon, the company issued a press release that provided an overview of its second quarter results, which followed ...

cbdMD (YCBD) Q2 2025 Earnings Call May 15, 2025 04:20 PM ET Speaker0 Good afternoon, and welcome to the CBDMD, Inc. Conference Call to discuss results for their second quarter fiscal twenty twenty five period ending 03/31/2025. This afternoon, the company issued a press release that provided an overview of its second quarter results, which followed the filing of its quarterly report on Form 10 Q. Today's conference call will be recorded and will be available online along with the earnings press release cove ...

cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal QuarterSuccessfully Completes Capital Structure Reset with Series A Preferred ConversionMay 15, 2025 4:09 PM EDT | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financia ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _______________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) North ...

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 ResultsMay 09, 2025 12:57 PM EDT | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year ...

Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North CarolinaMay 07, 2025 11:04 AM EDT | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - May 7, 2025) - Herbal Oasis ("Oasis"), the hemp derived THC-infused social seltzer brand redefining how people connect, unwind, and celebrate life, is now proud to be distributed by Carolina Premium Beverage, serving Charlotte NC and surrounding counties. Starting in May, consumers will be able to find Oasis on shelves ac ...

Core Viewpoint - cbdMD, Inc. announced the approval of the automatic conversion of its Series A Preferred Stock into Common Stock, which is expected to enhance its capital structure and eliminate significant dividend obligations [1][2]. Group 1: Shareholder Meeting Outcomes - Shareholders approved the automatic conversion of each share of Preferred Stock into thirteen shares of Common Stock, including all accumulated and unpaid dividends as of the Mandatory Exchange Date [1]. - The conversion is projected to eliminate approximately $6.7 million in accrued dividend payments as of March 31, 2025, and $4 million in annual dividend obligations, allowing the company to reinvest this capital into growth initiatives [2]. - Seven directors were elected for a term expiring at the 2026 annual meeting, Cherry Bekaert LLP was ratified as the independent registered public accounting firm, and an amendment for a reverse stock split was approved [2]. Group 2: Company Overview - cbdMD is recognized as a leading CBD company, offering a comprehensive line of THC-free CBD products and other brands such as Paw CBD, ATRx Labs, and Herbal Oasis [3]. - The company emphasizes its commitment to producing high-quality, U.S.-grown CBD products and aims to provide wellness-focused beverages through its Herbal Oasis brand [3].

Core Insights - cbdMD has achieved a significant milestone in the UK by advancing its Novel Food dossier (RP793) to the final phase of regulatory assessment with the UK Food Standards Agency (FSA), indicating a strong commitment to safety and quality in the CBD market [1][5] - The FSA's safety assessment confirms that cbdMD's proprietary CBD isolate meets UK food safety standards, paving the way for full authorization as a Novel Food [3][6] - The UK CBD market is projected to be worth £800 million in 2025, highlighting the growth potential for compliant CBD products [7] Regulatory Progress - cbdMD initiated the regulatory process in March 2021, submitting a comprehensive dossier that includes details on ingredient identity, quality, stability, and safety data [2] - In February 2022, cbdMD became the first U.S. brand to receive dossier validation from the FSA, demonstrating proactive engagement with regulatory authorities [2] - The FSA's safety assessment, published on February 28, 2025, confirms the high purity (>97%) of cbdMD's CBD isolate and its compliance with UK food safety regulations [3][6] Market Position and Consumer Confidence - cbdMD is positioned as a trusted brand in the CBD market, with a focus on providing safe and rigorously tested products [1][5] - The company is among the few legally authorized suppliers of CBD products in the UK, which is expected to enhance consumer awareness and drive sales [5] - The CEO of cbdMD emphasized that obtaining FSA approval will lead to greater consumer confidence and an expanded market share as demand for regulated CBD products rises [7]

Financial Data and Key Metrics Changes - Total net sales for Q1 fiscal 2025 were $5.1 million, a 12% increase from the prior year and a 12% increase from Q4 [12] - Gross profit remained at a healthy 66% for Q1 fiscal 2025 [13] - SG&A expenses decreased to $3.4 million from $4.6 million in the prior year [13] - The company achieved positive net income of $15,000 compared to a loss of $977,000 in Q1 fiscal 2024 [14] - Non-GAAP adjusted EBITDA was $214,000, a significant improvement from a loss of $698,000 in the prior year [14] Business Line Data and Key Metrics Changes - E-commerce direct-to-consumer sales were $3.9 million, a 10% year-over-year decrease, representing 77% of total net sales [12] - Wholesale business generated $1.1 million in net sales, up 22% compared to $950,000 in the prior year [12] Market Data and Key Metrics Changes - The beverage market is identified as the fastest-growing category within the CBD and hemp sectors, with significant growth observed in 2024 and continuing into 2025 [50][52] Company Strategy and Development Direction - The company is focused on achieving profitability and resolving capital structure challenges, with a clear roadmap for sustainable profitability [11][19] - New product launches, particularly in the Oasis social tonic line, are expected to drive future revenue growth [9][10] - The company is committed to enhancing its customer experience and optimizing its business operations [7][8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's financial progress and the potential for future growth, emphasizing the importance of addressing capital structure to unlock shareholder value [19][25] - The company has transformed into a leaner organization focused on long-term success despite challenges in the hemp and CBD industry [26] Other Important Information - The company is now debt-free, excluding ordinary course liabilities and accrued dividends, which allows for better cash management [17] - A proposal for a conversion ratio of one to thirteen for Series A preferred stock is aimed at improving capital structure and regaining compliance with NYSE standards [23][24] Q&A Session Summary Question: Progress on Oasis Social Tonics - Management noted that the product has been well-received, though wholesale distribution is slower than expected due to legal document iterations [33] Question: DTC Margins for Oasis - DTC margins for Oasis are tighter than other products, but the channel remains viable with potential for profitable growth [36] Question: Revenue from Oasis in December Quarter - Some revenue was booked in the December quarter, but it was limited due to the short time frame [38] Question: Total Shares Outstanding Post-Conversion - Total shares outstanding as of February post-conversion are just over 6.2 million [41] Question: Liquidity Runway - Management maintains a positive outlook on liquidity, expecting to operate a positive EBITDA business [42][43] Question: Future Working Capital Needs - Management anticipates more normal working capital relationships in upcoming quarters [44]